EU and Mexico Sign Updated Trade Deal to Reduce Dependence on US and China Leadership Change Casts Shadow Over PayPals Q1 Performance Setting Up Brokerage Accounts for Grandkids in a Parents Name Potential Pitfalls and Strategic Considerations Manchester City Faces Strategic Challenge as Bernardo Silva Departure Looms Financial and Squad Implications EUChina Competitive Gap for Automotive Suppliers Widening Warns CLEPA Another Airline Files for Bankruptcy and Suspends All Flight Operations ATMU Q1 2026 Earnings Earnings Per Share Slightly Beats Estimates Amid Positive Market Reaction Life Time Group Holdings LTH Q1 2026 Earnings EPS Beats Estimates as Membership Trends Strengthen Stock Slips UAA Q1 2026 Earnings EPS Miss Amid Strategic Restructuring Progress Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady Digital Brands Group DBGI Q3 2023 Earnings Heavy Loss Per Share and Sharp Stock Decline Amidst Operational Challenges FTAIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Presidio Property Trust Series D Preferred SQFTP Slips 172 as Preferred Shares Test Key Levels Hongli Group HLP Faces Resistance Near 050 as Stock Slips by 095 Expand Energy EXE Edges Higher as Natural Gas Markets Show Signs of Stability Lululemon LULU Edges Higher Amid Consolidation Near Key Resistance Level Occidental Petroleum OXY Slides 099 as Energy Sector Struggles Key Support Levels Tested STC Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Title Volume BHFAO Q1 2026 Earnings Preferred Series B Misses on EPS Despite Modest Stock Uptick FRAF Q1 2026 Earnings EPS Beats Estimates by 828 Stock Rises Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress APYX Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty Shares Slip SAM Q1 2026 Earnings EPS Misses Estimates Stock Still Gains Ground SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway in Market Cap on Debut BUD Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus Editas Medicine Surges 1591 Gene Editing Stock Breaks Above Key Support